September 5, 2023
The right medical combination
There is anticipation mixed with nervousness, but after a decade’s work, Argenica is at the point of delivering ARG-007 to patients.
Category: Health
September 1, 2023
Paradigm hits the road with new inflammation treatment
Paradigm Biopharmaceutical will feature their injectable PPS for treating osteoarthritis and mucopolysaccharidosis at international conferences.
August 25, 2023
Clarity (ASX:CU6) get clear sight on prostate treatment
A swift recruitment process for its trial escalation shows high demand for better and more accessible prostate cancer therapy.
August 22, 2023
EMVision (ASX:EMV) make a stroke care breakthrough
Initial studies confirm 100 per cent success in producing processable signals using a novel and advanced AI-powered imagining technique.
August 1, 2023
Argenica (ASX:AGN) show ARG-007 treating the Parkinson’s Protein
After a research breakthrough in Parkinson’s treatment, Argenica have reinforced the potential of ARG-007 to treat a range of neurological issues.
July 20, 2023
Argenica (ASX:AGN) advancing ARG-007 to Phase 2
With potential to treat a range of brain issues, Argenica is advancing ARG-007 to stage 2 stroke trials with some of Australia’s eminent experts.
June 22, 2023
Argenica (ASX:AGN) show ARG-007 reducing traumatic brain injuries
Preclinical trials on a rat model show Argenica’s novel therapeutic for stroke patients significantly reduces brain cell damage.
June 9, 2023
Frugl (ASX:FGL) grow into Asia
Frugl strike an accord to bring its health tech to a prominent United Arab Emirates retailer about to embark on a dynamic growth phase.
June 9, 2023
Limeade (ASX:LME) selling to WebMD
While sold a heady recent premium, a 42.5c sale ends the decline for an Australian company who once traded above $2 during the pandemic.
June 6, 2023
Memphasys (ASX: MEM) leads the pack in sperm separation
Study shows FelixTM System offers significant advantages over alternative sperm
separation techniques on cryopreserved semen.